New therapeutic options for IBS: the role of the first in class mixed micro-opioid receptor agonist and delta-opioid receptor antagonist (mudelta) eluxadoline - Corsetti, M; Whorwell, P (Expert Rev Gastroenterol Hepatol, 2017)